VTRS - Teva upgraded at J.P. Morgan on upcoming catalysts
2024-03-08 10:21:57 ET
More on Teva Pharmaceutical
- Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities
- Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Position
- A Review Of Teva's Prospects
- UroGen falls as Teva seeks FDA nod for Jelmyto generic
- Biggest stock movers today: Alcoa, Domino's Pizza, Li Auto, Intuitive Machines, and more